The research focuses on how to target specific sections of DNA inside cells Researchers targeted MYC, a gene linked to cancer growth Modified DNA molecules reduced MYC activity by 50 - 80% in laboratory tests Newswise — Researchers have developed a promising new approach…
Based on existing gene therapies for other conditions, initial estimates suggest a single course of CRISPR longevity treatment could cost anywhere from hundreds of thousands to several million dollars. For example, some current gene therapies already exceed $2 million per treatment.
This approach is elegant in its simplicity and powerful in its effect. It doesn’t replace the faulty gene; it strategically disrupts another gene in the pathway to mitigate the disease’s symptoms. It’s a clever workaround that demonstrates the versatility and…
WEHI researchers have discovered a way to release a genetic 'brake' that silences healthy genes in Prader-Willi syndrome, opening a potential new path to treating the condition. About 400,000 people worldwide live with Prader-Willi syndrome, a complex and devastating condition that…
Results from a phase I clinical trial led by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) show a possible way to improve therapy options for patients with…
A team of researchers led by Cardiff University has developed a promising new gene-editing approach that could transform the treatment of Huntington's disease in the future. Huntington's disease is caused by repetitive "stutters" in DNA - specifically repeated CAG sequences - that…
Could experimental gene therapy change what’s possible for children with Hunter syndrome, also known as MPS II? In this episode, a father describes his son’s gene therapy treatment journey and reports his progress. We discuss how the therapy works, the…
Silencing the Huntingtin gene using ASO drugs reaches further, lasts longer and is safe. Human trial soon? Since the HD gene was identified, nearly 20 years ago, scientists have been trying to understand what it does, how it causes the symptoms…
Growing evidence for CAR-T and its expanding use across hematologic malignancies are fueling comparisons with stem cell transplantation. Their relative roles differ sharply by disease and clinical setting. The latest EBMT activity survey, covering 2024, recorded 47,204 HCT procedures. Allo-HCT rose 2.6% from…
As scientific advancements in genetic engineering and reproductive technologies rapidly progress in the AI age, the prospect of designer babies—children whose traits are selected or altered using genetic modification—is no longer confined to the realm of science fiction.
CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up.
An article joins this feed when it matches these terms. Each one is also a search of its own.